Werewolf Therapeutics, Inc.
HOWL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $90 | $49 | $44 | $66 |
| - Cash | $67 | $78 | $92 | $111 |
| + Debt | $10 | $37 | $37 | $37 |
| Enterprise Value | $33 | $8 | -$11 | -$8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15 | -$16 | -$16 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$16 | -$18 | -$18 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.4 | -0.4 | -0.46 |
| % Growth | 10% | 0% | 13% | – |
| Operating Cash Flow | -$15 | -$15 | -$19 | -$14 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$15 | -$15 | -$19 | -$14 |